Category - Executive Moves

Executive Moves

RNADD adds renowned pro sports team physician Michael Farber to advisory board

Michael Farber Closely-held RNA Disease Diagnostics appointed board-certified internist and professional sports physician, Michael Farber, M.D., to its advisory board. Dr. Farber is the medical director of executive...

September 2, 2021

Executive Moves

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) named Dr. Srinivas (Srini) Rao, M.D., Ph.D., and Frank Stegert to the board, reflecting a previously disclosed purchaser rights agreement with atai Life Sciences AG. With...

August 4, 2021

Executive Moves

EyeGate Pharma names Brian Strem as president and CEO

Brian Strem EyeGate Pharmaceuticals (NASDAQ:EYEG) appointed Brian Strem, Ph.D., as president, CEO and a director, effective immediately. He replaces acting CEO, Franz Obermayr, Ph.D., who reassumes his position as...

July 28, 2021

Executive Moves

Kyle Mikson joins Canaccord Genuity as director, senior equity research

Kyle Mikson Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector. Mr. Mikson will focus on expanding the firm’s footprint on...

July 9, 2021

Executive Moves

Healthcare veteran Richard Ganz joins RNA Disease Diagnostics board

Closely-held RNA Disease Diagnostics appointed Robert Ganz, a healthcare veteran with more than 40 years of executive experience in venture-backed startups and international healthcare companies, to the board. Mr. Ganz...

July 8, 2021

Executive Moves

Q32 Bio names Adam Cutler as CFO

Adam Cutler Closely-held Q32 Bio appointed Adam Cutler as chief financial officer, with responsibility for all aspects of its financial strategy and operations. Mr. Cutler has more than 20 years of experience in...

July 7, 2021

Executive Moves

Talkiatry names Jared Camins as CTO

Talkiatry appoints Jared Camins as Chief Technology Officer Closely-held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed...

June 22, 2021

Executive Moves

PharmaJet names Paul LaBarre as VP global business development

Paul LaBarre PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for...

June 15, 2021

Executive Moves

Accelmed Partners bolsters senior HealthTech executive team

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

June 14, 2021

Executive Moves

RNA Disease Diagnostics adds John Erickson Jr. as president

John Erickson Jr. RNA Disease Diagnostics (RNADD) appointed John Erickson, Jr. to the newly created position of president to lead day-to-day operations. He will report directly to company co-founder and executive...

June 1, 2021

Category - Executive Moves

Subscribe